Stockscreener 앱 받기
1.38
2.22%
0.03
시간 외 거래:
1.39
0.01
+0.72%
전일 마감가:
$1.35
열려 있는:
$1.37
하루 거래량:
1.55M
Relative Volume:
0.67
시가총액:
$315.13M
수익:
$8.95M
순이익/손실:
$-21.49M
주가수익비율:
-11.50
EPS:
-0.12
순현금흐름:
$-29.24M
1주 성능:
+8.66%
1개월 성능:
+15.00%
6개월 성능:
+165.38%
1년 성능:
+48.55%
1일 변동 폭
$1.32
$1.42
1주일 범위
$1.20
$1.42
52주 변동 폭
$0.3651
$1.42
Lineage Cell Therapeutics Inc Stock (LCTX) Company Profile
명칭
Lineage Cell Therapeutics Inc
전화
510-871-4188
주소
2173 Salk Avenue, Suite 200, Carlsbad, CA
LCTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LCTX
Lineage Cell Therapeutics Inc
|
1.38 | 308.28M | 8.95M | -21.49M | -29.24M | -0.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.36 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.06 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
752.32 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Lineage Cell Therapeutics Inc Stock (LCTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-20 | 개시 | Craig Hallum | Buy |
| 2022-11-02 | 개시 | Robert W. Baird | Outperform |
| 2022-06-14 | 개시 | B. Riley Securities | Buy |
| 2021-08-19 | 개시 | Noble Capital Markets | Outperform |
| 2021-03-31 | 개시 | Cantor Fitzgerald | Overweight |
Lineage Cell Therapeutics Inc 주식(LCTX)의 최신 뉴스
Volume spikes in Lineage Cell Therapeutics Inc. stock – what they mean2025 Dividend Review & Fast Gaining Stock Strategy Reports - newser.com
Aug Spikes: Can Lineage Cell Therapeutics Inc. maintain sales growthWeekly Market Report & High Return Trade Opportunity Guides - خودرو بانک
Growth Value: Will Lineage Cell Therapeutics Inc stock hit new highs in YEARLayoff News & Precise Swing Trade Entry Alerts - خودرو بانک
FOMO Trade: Will Lineage Cell Therapeutics Inc benefit from rising consumer demandCPI Data & Trade Opportunity Analysis Reports - خودرو بانک
Aug Weekly: Can Lineage Cell Therapeutics Inc benefit from deglobalizationMarket Growth Summary & Risk Adjusted Buy and Sell Alerts - خودرو بانک
Aug Shorts: Does Lineage Cell Therapeutics Inc. offer margin of safetyJuly 2025 Review & Stock Market Timing Techniques - خودرو بانک
Movement Recap: Can Lineage Cell Therapeutics Inc. lead its sector in growth2025 AllTime Highs & Capital Protection Trade Alerts - خودرو بانک
Will Lineage Cell Therapeutics Inc. continue its uptrendWeekly Stock Summary & Smart Swing Trading Techniques - newser.com
Published on: 2025-09-15 21:14:53 - خودرو بانک
Market Review: How does Lineage Cell Therapeutics Inc compare to its peersPortfolio Performance Summary & Weekly Setup with ROI Potential - خودرو بانک
Earnings Risk: Can Lineage Cell Therapeutics Inc maintain sales growthJuly 2025 Weekly Recap & Stepwise Swing Trade Plans - خودرو بانک
Can trapped investors hope for a rebound in Lineage Cell Therapeutics Inc.July 2025 Trends & Momentum Based Trading Ideas - newser.com
Can momentum traders help lift Lineage Cell Therapeutics Inc.2025 Dividend Review & Community Supported Trade Ideas - newser.com
Visual trend scoring systems applied to Lineage Cell Therapeutics Inc.Quarterly Portfolio Review & High Return Trade Guides - newser.com
Pattern recognition hints at Lineage Cell Therapeutics Inc. upsideJuly 2025 Catalysts & Community Consensus Stock Picks - Newser
MAI Capital Management Sells 593,288 Shares of Lineage Cell Therapeutics, Inc. $LCTX - MarketBeat
Nuveen LLC Makes New Investment in Lineage Cell Therapeutics, Inc. $LCTX - MarketBeat
Lineage Cell Therapeutics stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com Nigeria
Lineage Cell Therapeutics stock maintains Buy rating at H.C. Wainwright - Investing.com
Lineage Cell Therapeutics Initiates Cell Transplant Program In Type 1 Diabetes - BioSpace
Comerica Bank Grows Position in Lineage Cell Therapeutics, Inc. $LCTX - MarketBeat
Lineage Cell Therapeutics at H.C. Wainwright: Advancing Cell Therapies By Investing.com - Investing.com Canada
Lineage Cell Therapeutics, Inc. Initiates Cell Transplant Program in Type 1 Diabetes - MarketScreener
Lineage Cell Therapeutics initiates cell transplant program in type 1 diabetes - MarketScreener
Lineage Nabs $12M Demant Partnership - San Diego Business Journal
Broadwood Capital Inc. Has $22.38 Million Stock Position in Lineage Cell Therapeutics, Inc. $LCTX - MarketBeat
Real time scanner hits for Lineage Cell Therapeutics Inc. explainedEarnings Summary Report & Community Trade Idea Sharing - Newser
Can Lineage Cell Therapeutics Inc. deliver alphaShort Setup & Growth Oriented Trading Recommendations - خودرو بانک
Published on: 2025-09-06 02:25:51 - خودرو بانک
Can Lineage Cell Therapeutics Inc. withstand a market correctionJuly 2025 Volume & Low Drawdown Investment Strategies - خودرو بانک
Combining price and volume data for Lineage Cell Therapeutics Inc.Weekly Investment Report & Fast Moving Trade Plans - Newser
Is Lineage Cell Therapeutics Inc. stock influenced by commodity pricesMarket Sentiment Report & Short-Term Trading Alerts - خودرو بانک
Should you wait for a breakout in Lineage Cell Therapeutics Inc.2025 Buyback Activity & Reliable Entry Point Alerts - Newser
How sentiment analysis helps forecast Lineage Cell Therapeutics Inc.2025 Momentum Check & Weekly Chart Analysis and Guides - Newser
How to read the order book for Lineage Cell Therapeutics Inc.Stop Loss & High Conviction Investment Ideas - Newser
How to use Fibonacci retracement on Lineage Cell Therapeutics Inc.Analyst Downgrade & Daily Volume Surge Signals - Newser
Can technical indicators confirm Lineage Cell Therapeutics Inc.’s reversal2025 Market Sentiment & Community Driven Trade Alerts - Newser
What are analysts’ price targets for Lineage Cell Therapeutics Inc.Weekly Risk Report & Low Volatility Stock Recommendations - خودرو بانک
Analyzing recovery setups for Lineage Cell Therapeutics Inc. investorsJuly 2025 Momentum & Accurate Entry and Exit Point Alerts - Newser
Will Lineage Cell Therapeutics Inc. outperform the marketTrade Volume Summary & Verified Chart Pattern Signals - Newser
can technical indicators confirm lineage cell therapeutics inc.’s reversalGDP Growth & Stock Portfolio Risk Control - Newser
What data driven models say about Lineage Cell Therapeutics Inc.’s futureEarnings Risk Summary & Daily Technical Forecast Reports - Newser
Does Lineage Cell Therapeutics Inc. show high probability of reboundQuarterly Trade Report & Trade Opportunity Analysis Reports - Newser
Published on: 2025-09-04 04:56:57 - Newser
Published on: 2025-09-04 08:56:10 - خودرو بانک
Is it time to cut losses on Lineage Cell Therapeutics Inc.2025 EndofYear Setup & Growth Focused Stock Reports - Newser
Is Lineage Cell Therapeutics Inc. still worth holding after the dipProfit Target & Weekly Momentum Stock Picks - Newser
Does Lineage Cell Therapeutics Inc. offer margin of safetyJuly 2025 Price Swings & Reliable Trade Execution Plans - خودرو بانک
Is it too late to sell Lineage Cell Therapeutics Inc.Quarterly Performance Summary & Risk Managed Trade Strategies - Newser
Evaluating Lineage Cell Therapeutics Inc. with trendline analysisWeekly Market Summary & Fast Momentum Stock Entry Tips - Newser
Spinal Cord Injury Pipeline 2025: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights By DelveInsight | StemCyte, NervGen Pharma, VA Office of Research and Development - The Globe and Mail
Lineage Cell Therapeutics Inc (LCTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.77%
1.53%
자본화:
|
볼륨(24시간):